Delivery Order SPE2DB25D7056-SPE2DB25FTMRY
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-count package, with a ceiling value of $4,539.09 and a completion date of July 22, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. Ondansetron is an antiemetic...
- The Defense Logistics Agency awarded a delivery order valued at approximately $26,000 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with completion expected by July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $6,633.04. This firm fixed-price delivery order represents a non-set-aside award issued under competitive procurement and is scheduled for completion by July 28, 2025. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $3,747.17 and is scheduled for completion by June 23, 2025. The contract does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count units) with a ceiling value of $4,348.93. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by July 21, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron, a commonly prescribed...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ondansetron ODT 8 mg tablets in a 30-tablet configuration. This firm fixed-price delivery order carries a ceiling value of $2,606.12 and is scheduled for completion by August 12, 2025. The contract was competitively awarded with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Ondansetron ODT 4 mg tablets in a 30-count package. This contract, valued at $2,396.05, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is set for ultimate completion on July 15, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) valued at $3,534.12. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for completion by April 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Ondansetron is a widely-used...
- The Defense Logistics Agency awarded a $5,630.06 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count) on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract is classified as a firm fixed price delivery order and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is an antiemetic medication commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a $1,611.89 delivery order to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Ondansetron ODT 4 MG tablets in quantities of 30 units. This is a firm fixed price delivery order with a completion deadline of May 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. Ondansetron is an antiemetic medication commonly used in military and veteran...
- SPE2DB25D7056Indefinite Delivery Contract
- SPE2DB25D7056-SPE2DB25FTMRYDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 1, 2025, for the supply of Ondansetron ODT 4 mg tablets (30-count packages) with a ceiling value of $11,141.88. This firm fixed-price delivery order, which must be completed by July 2, 2025, represents a non-competitive set-aside arrangement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a widely used antiemetic medication commonly prescribed for nausea and vomiting prevention, particularly in military and veteran healthcare settings. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The parent IDC serves as a flexible global pharmaceutical support vehicle enabling the company to fulfill diverse medical supply requirements across multiple therapeutic domains for military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.1k | 7/1/25 |